Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer.

Danarto R, Astuti I, Umbas R, Haryana SM.

Turk J Urol. 2019 Nov 29;46(1):26-30. doi: 10.5152/tud.2019.19163.

2.
3.

Report of the third Asian Prostate Cancer study meeting.

Lojanapiwat B, Lee JY, Gang Z, Kim CS, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Lee SH, Türkeri L, Murphy DG, Moretti K, Cooperberg M, Carlile R, Hinotsu S, Hirao Y, Kitamura T, Horie S, Onozawa M, Kitagawa Y, Namiki M, Fukagai T, Miyazaki J, Akaza H.

Prostate Int. 2019 Jun;7(2):60-67. doi: 10.1016/j.prnil.2018.06.001. Epub 2018 Jun 14.

4.

Report of the forth Asian Prostate Cancer (A-CaP) study meeting.

Youl Lee J, Taniguchi T, Zhang K, Ng CF, Hakim L, Umbas R, Kim CS, Chung BH, Kim WJ, Aik Ong T, Lim J, Akaza H.

Jpn J Clin Oncol. 2019 Jun 1;49(6):581-586. doi: 10.1093/jjco/hyz053.

PMID:
31141613
5.

The importance of targeting intracrinology in prostate cancer management.

Hamid ARAH, Tendi W, Sesari SS, Mochtar CA, Umbas R, Verhaegh G, Schalken JA.

World J Urol. 2019 May;37(5):751-757. doi: 10.1007/s00345-018-2529-7. Epub 2018 Oct 22. Review.

PMID:
30350016
6.

Recent advances in optical imaging technologies for the detection of bladder cancer.

Raharja PAR, Hamid ARAH, Mochtar CA, Umbas R.

Photodiagnosis Photodyn Ther. 2018 Dec;24:192-197. doi: 10.1016/j.pdpdt.2018.10.009. Epub 2018 Oct 10. Review.

PMID:
30315954
7.

Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia.

Afriansyah A, Hamid ARA, Mochtar CA, Umbas R.

Int J Urol. 2019 Jan;26(1):83-89. doi: 10.1111/iju.13813. Epub 2018 Sep 30.

8.

Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.

Chiong E, Murphy DG, Akaza H, Buchan NC, Chung BH, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Ng CF, Ong T, Pu YS, Saad M, Schubach K, Türkeri L, Umbas R, Le Chuyen V, Williams S, Ye DW; ANZUP Cancer Trials Group, Davis ID.

BJU Int. 2019 Jan;123(1):22-34. doi: 10.1111/bju.14489. Epub 2018 Aug 19. Review.

9.

Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis.

Afriansyah A, Hamid ARAH, Mochtar CA, Umbas R.

F1000Res. 2018 Feb 28;7:246. doi: 10.12688/f1000research.14026.1. eCollection 2018.

10.

Case of perinephric abscess disguising as renal tumor.

Raharja PAR, Hamid ARAH, Mochtar CA, Umbas R.

Urol Case Rep. 2018 Mar 1;18:35-37. doi: 10.1016/j.eucr.2018.02.021. eCollection 2018 May. No abstract available.

11.

Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting.

Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Wu TL, Lojanapiwat B, Türkeri L, Murphy DG, Gardiner RA, Moretti K, Cooperberg M, Carroll P, Mun SK, Hinotsu S, Hirao Y, Ozono S, Horie S, Onozawa M, Kitagawa Y, Kitamura T, Namiki M, Akaza H.

Prostate Int. 2017 Sep;5(3):95-103. doi: 10.1016/j.prnil.2017.03.006. Epub 2017 Mar 29.

12.

Symposium: "Oncology Leadership in Asia".

Noh DY, Roh JK, Kim YH, Yoshida K, Baba H, Samson-Fernando MC, Misra S, Aziz Z, Umbas R, P Singh Y, Shu Kam Mok T, Yang HK, Akaza H.

Cancer Res Treat. 2017 Apr;49(2):283-291. doi: 10.4143/crt.2017.090. Epub 2017 Mar 9.

13.

Prostate cancer detection rate in Indonesian men.

Mochtar CA, Atmoko W, Umbas R, Hamid ARAH.

Asian J Surg. 2018 Mar;41(2):163-169. doi: 10.1016/j.asjsur.2017.01.001. Epub 2017 Feb 14.

14.

Targeted Therapy for Metastatic Renal Cell Carcinoma.

Afriansyah A, Hamid AR, Mochtar CA, Umbas R.

Acta Med Indones. 2016 Oct;48(4):335-347. Review.

15.

Surgical Management of Giant Genital Condyloma Acuminata by Using Double Keystone Flaps.

Eriad Yunir P, Mochtar CA, Hamid AR, Sukasah CL, Umbas R.

Case Rep Urol. 2016;2016:4347821. Epub 2016 Nov 16.

16.

Thrombus-like Tumor of Renal Cell Carcinoma Mimicking Transitional Cell Carcinoma of Kidney: A Case Report.

Parikesit D, Mochtar CA, Tanurahardja B, Matondang S, Umbas R, Hamid AR.

Urol Case Rep. 2016 Nov 22;10:26-29. eCollection 2017 Jan.

17.

The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review.

Perdana NR, Mochtar CA, Umbas R, Hamid AR.

Acta Med Indones. 2016 Jul;48(3):228-238. Review.

18.

Asia prostate cancer study (A-CaP Study) launch symposium.

Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong TA, Lojanapiwat B, Wu TL, Kim WJ, Murphy D, Ogawa O, Carroll P, Naito S, Tsukamoto T.

Prostate Int. 2016 Sep;4(3):88-96. doi: 10.1016/j.prnil.2016.03.001. Epub 2016 Mar 10.

19.

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia.

Putra IB, Hamid AR, Mochtar CA, Umbas R.

Prostate Int. 2016 Jun;4(2):43-8. doi: 10.1016/j.prnil.2016.03.002. Epub 2016 Mar 11.

20.

The impact of obesity towards prostate diseases.

Parikesit D, Mochtar CA, Umbas R, Hamid AR.

Prostate Int. 2016 Mar;4(1):1-6. doi: 10.1016/j.prnil.2015.08.001. Epub 2015 Nov 24. Review.

21.

Indonesian prostate cancer risk calculator (IPCRC): an application for predicting prostate cancer risk (a multicenter study).

Yuri P, Wangge G, Abshari F, Satjakoesoemah AI, Perdana NR, Wijaya CD, Tansol C, Tigor A, Safriadi F, Kadar DD, Warli SM, Rochadi S, Danarto, Hakim L, Djatisoesanto W, Hardjowijoto S, Mochtar CA, Umbas R, Hamid AR.

Acta Med Indones. 2015 Apr;47(2):95-103.

22.

Urologic cancer in Indonesia.

Umbas R, Safriadi F, Mochtar CA, Djatisoesanto W, Hamid AR.

Jpn J Clin Oncol. 2015 Aug;45(8):708-12. doi: 10.1093/jjco/hyv066. Epub 2015 Jun 16. Review.

PMID:
26085688
23.

Effective dose and adverse effects of maintenance Bacillus Calmette-Gue'Rin in intermediate and high risk non-muscle invasive bladder cancer: a meta-analysis of randomized clinical trial.

Astram A, Khadijah A, Yuri P, Zulfan A, Mochtar CA, Danarto R, Umbas R, Hamid AR.

Acta Med Indones. 2014 Oct;46(4):298-307. Review.

24.

Prostate cancer in Asia: A collaborative report.

Chen R, Ren S; Chinese Prostate Cancer Consortium, Yiu MK, Fai NC, Cheng WS, Ian LH, Naito S, Matsuda T, Kehinde E, Kural A, Chiu JY, Umbas R, Wei Q, Shi X, Zhou L, Huang J, Huang Y, Xie L, Ma L, Yin C, Xu D, Xu K, Ye Z, Liu C, Ye D, Gao X, Fu Q, Hou J, Yuan J, He D, Pan T, Ding Q, Jin F, Shi B, Wang G, Liu X, Wang D, Shen Z, Kong X, Xu W, Deng Y, Xia H, Cohen AN, Gao X, Xu C, Sun Y.

Asian J Urol. 2014 Oct;1(1):15-29. doi: 10.1016/j.ajur.2014.08.007. Epub 2015 Apr 16.

25.

Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.

Supit W, Mochtar CA, Santoso RB, Umbas R.

Asian J Surg. 2014 Oct;37(4):184-9. doi: 10.1016/j.asjsur.2014.01.010. Epub 2014 Mar 14.

26.

Anxiety level of early- and late-stage prostate cancer patients.

Johanes C, Monoarfa RA, Ismail RI, Umbas R.

Prostate Int. 2013;1(4):177-82. doi: 10.12954/PI.13027. Epub 2013 Dec 30.

27.

Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management.

Akaza H, Kim CS, Carroll P, Choi IY, Chung BH, Cooperberg MR, Hirao Y, Hinotsu S, Horie S, Lee JY, Namiki M, Ng CF, Onozawa M, Ozono S, Ueno S, Umbas R, Ye D, Zhu G.

Prostate Int. 2014;2(2):50-69. doi: 10.12954/PI.14047. Epub 2014 Jun 30.

28.

Outcomes and predictors of localized or locally-advanced prostate cancer treated by radiotherapy in Indonesia.

Supit W, Mochtar CA, Santoso RB, Umbas R.

Prostate Int. 2013;1(1):16-22. doi: 10.12954/PI.12012. Epub 2013 Feb 4.

29.

Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.

Williams S, Chiong E, Lojanapiwat B, Umbas R, Akaza H; Asian Oncology Summit 2013.

Lancet Oncol. 2013 Nov;14(12):e524-34. doi: 10.1016/S1470-2045(13)70451-0. Review.

PMID:
24176571
31.

Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes.

Akaza H, Hinotsu S, Cooperberg MR, Chung BH, Youl Lee J, Umbas R, Tsukamoto T, Namiki M, Carroll P.

Jpn J Clin Oncol. 2013 Jul;43(7):756-66. doi: 10.1093/jjco/hyt071. Epub 2013 May 29.

32.

Prostate cancer in younger and older patients: do we treat them differently?

Situmorang GR, Umbas R, Mochtar CA, Santoso RB.

Asian Pac J Cancer Prev. 2012;13(9):4577-80.

33.

Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.

Chiong E, Tay MH, Tan MH, Kumar S, Sim HG, Teh BT, Umbas R, Chau NM.

Lancet Oncol. 2012 Nov;13(11):e482-91. doi: 10.1016/S1470-2045(12)70433-3. Review.

PMID:
23117003
34.
35.

Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.

Supit W, Mochtar CA, Sugiono M, Umbas R.

Asian Pac J Cancer Prev. 2011;12(2):549-53.

36.

Recent role of inflammation in prostate diseases: chemoprevention development opportunity.

Hamid AR, Umbas R, Mochtar CA.

Acta Med Indones. 2011 Jan;43(1):59-65. Review.

37.

Testicular metastases from prostate carcinoma.

Rahardjo HE, Umbas R, Sutisna H.

Asian J Surg. 2010 Jul;33(3):154-6. doi: 10.1016/S1015-9584(10)60026-7.

38.

Prostate Cancer Working Group report.

Namiki M, Akaza H, Lee SE, Song JM, Umbas R, Zhou L, Lee BC, Cheng C, Chung MK, Fukagai T, Hinotsu S, Horie S.

Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i70-75. doi: 10.1093/jjco/hyq130.

PMID:
20870924
39.

Testosterone replacement therapy in prostate cancer patients: is it safe?

Umbas R, Sugiono M.

Acta Med Indones. 2010 Jul;42(3):171-5. Review.

40.

Recent progressions in stem cell research: breakthroughs achieved and challenges faced.

Tani J, Umbas R.

Acta Med Indones. 2009 Jan;41(1):30-5. Review.

41.

Metastasis of testicular carcinoma in the inguinal region.

Hamid AR, Umbas R.

Acta Med Indones. 2009 Jan;41(1):25-9.

43.

The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy.

Akaza H, Moore MA, Chang SJ, Cheng C, Choi HY, Esuvaranathan K, Hinotsu S, Hong SJ, Kim CS, Kim WJ, Murai M, Naito S, Soebadi D, Song JM, Umbas R, Usami M, Xia S, Yang CR.

Asian Pac J Cancer Prev. 2007 Jan-Mar;8(1):3-12.

44.

Prostate cancer control--aims of the UICC Asia Regional Office Consortium.

Cheng C, Akaza H, Chen KK, Moore MA, Naito S, Song JM, Umbas R, Xia S; UICC ARO Prostate Cancer Consortium.

Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):350-68. Review.

45.

The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy.

Akaza H, Naito S, Chang SJ, Chen KK, Cheng C, Choi HY, Fujioka T, Hinotsu S, Hirao Y, Hong SJ, Kim CS, Kim WJ, Lee SE, Murai M, Ogawa O, Rim JS, Soebadi DM, Song JM, Tsukamoto T, Umbas R, Usami M, Xia S, Yang CR, Yoon JH, Zhou L.

Gan To Kagaku Ryoho. 2004 Aug;31(8):1285-95.

PMID:
15332559
46.

The 2nd conference on Asian trends in prostate cancer hormone therapy.

Akaza H, Chang SJ, Chen KK, Esuvaranathan K, Fujioka T, Hirao Y, Hong SJ, Hinotsu S, Kim WJ, Lau W, Lee SE, Murai M, Naito S, Ogawa O, Rim JS, Soebadi DM, Song JM, Tsukamoto T, Umbas R, Usami M, Yang CR, Yoon JH, Zhou L.

Gan To Kagaku Ryoho. 2003 Oct;30(10):1533-42.

PMID:
14584292
47.

Asian trends in prostate cancer hormone therapy.

Akaza H, Naito S, Cheng C, Kaisary A, Soebadi DM, Umbas R, Esuvaranathan K, Gu FL, Zhou L, Hong SJ, Kim WJ, Lee SE, Rim JS, Song JM, Yoon JH, Chang SJ, Huang CH, Yang CR, Hirao Y, Murai M, Tsukamoto T, Usami M.

Gan To Kagaku Ryoho. 2002 Nov;29(11):1951-61.

PMID:
12465395
48.

A higher PSA-density cut-off level in patients with intermediate PSA values for the early detection of prostate cancer.

Mochtar CA, Rahardjo D, Umbas R.

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:514-22.

PMID:
10895203
49.

Mechanisms associated with abnormal E-cadherin immunoreactivity in human bladder tumors.

Bringuier PP, Giroldi LA, Umbas R, Shimazui T, Schalken JA.

Int J Cancer. 1999 Nov 26;83(5):591-5.

50.

Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma.

Xue Y, Li J, Latijnhouwers MA, Smedts F, Umbas R, Aalders TW, Debruyne FM, De La Rosette JJ, Schalken JA.

Br J Urol. 1998 Jun;81(6):844-51.

PMID:
9666769

Supplemental Content

Support Center